Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | MAP2K7 | O14733 | 1/20 | 0.39 |
| ▸ | GMNN | O75496 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | CDC25A | P30304 | 1/20 | 0.39 |
| ▸ | CDC25B | P30305 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9910017 | 0.85 | ALDH1A1 (0.46) | ALDH1A1KDM4EHSD17B10LMNAPOLB | |
| SCHEMBL29441612 | 0.83 | ALDH1A1 (0.52) | ALDH1A1KDM4EHSD17B10POLBALOX15 | |
| SCHEMBL11213802 | 0.83 | ALDH1A1 (0.52) | ALDH1A1KDM4EHSD17B10POLBALOX15 | |
| SCHEMBL8577595 | 0.81 | ALDH1A1 (0.46) | ALDH1A1KDM4EHSD17B10LMNAPOLB | |
| SCHEMBL17687693 | 0.80 | KDM4E (0.42) | ALDH1A1KDM4EHSD17B10LMNACYP1A2 | |
| SCHEMBL15826903 | 0.80 | ALDH1A1 (0.33) | ALDH1A1KDM4EHSD17B10LMNAPOLB | |
| SCHEMBL13292304 | 0.79 | ALDH1A1 (0.44) | ALDH1A1KDM4EHSD17B10LMNAPOLB | |
| SCHEMBL13302911 | 0.79 | POLB (0.45) | ALDH1A1KDM4EHSD17B10POLBTSHR | |
| SCHEMBL232522 | 0.79 | ALDH1A1 (0.44) | ALDH1A1KDM4EHSD17B10LMNAPOLB | |
| SCHEMBL30408659 | 0.79 | POLB (0.45) | ALDH1A1KDM4EHSD17B10POLBTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230233551-A1 | COMPOSITIONS AND METHODS FOR TREATMENT | CITIBANK, N.A., AS NOTES COLLATERAL AGENT | 2023-07-27 | — | — | US | disclosed |
| US-20230233551-A1 | COMPOSITIONS AND METHODS FOR TREATMENT | CITIBANK, N.A., AS NOTES COLLATERAL AGENT | 2023-07-27 | — | — | US | disclosed |
| US-11691957-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-07-04 | — | — | US | disclosed |
| US-11691957-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-07-04 | — | — | US | disclosed |
| US-RE49569-E1 | Alkylamine derivative | EA PHARMA CO., LTD. (JP) | 2023-07-04 | — | — | US | disclosed |
| US-11691957-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-07-04 | — | — | US | disclosed |
| US-20210338839-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETIC RETINOPATHY | NOVARTIS AG (CH) | 2021-11-04 | — | — | US | disclosed |
| US-20210198222-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2021-07-01 | — | — | US | disclosed |
| US-20210198222-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2021-07-01 | — | — | US | disclosed |
| EP-3797775-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETIC RETINOPATHY | Novartis AG (CH) | 2021-03-31 | — | — | EP | disclosed |
| US-7358254-B2 | Method for treating atherosclerosis employing an aP2 inhibitor and combination | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-04-15 | — | — | US | disclosed |
| US-20070031514-A1 | Use of isoindolinone derivatives as insecticides | BAYER CROPSCIENCE AG (DE) | 2007-02-08 | — | — | US | disclosed |
| US-20070031514-A1 | Use of isoindolinone derivatives as insecticides | BAYER CROPSCIENCE AG (DE) | 2007-02-08 | — | — | US | disclosed |
| US-6103912-A | OPTICAL INFRARED FILTERS COMPRISING PH SENSITIVE DYES | POLAROID CORPORATION (US) | 2000-08-15 | — | — | US | disclosed |
| EP-0553346-B1 | PHOTOGRAPHIC PRODUCTS AND PROCESSES | POLAROID CORP (US) | 1998-01-28 | — | — | EP | disclosed |
| US-5244771-A | Bridged indicator dyes used as light-absorbing, pH-sensitive optical filter agents in diffusion transfer | POLAROID CORPORATION (US) | 1993-09-14 | — | — | US | disclosed |
| EP-0553346-A1 | PHOTOGRAPHIC PRODUCTS AND PROCESSES | POLAROID CORPORATION (US) | 1993-08-04 | — | — | EP | disclosed |
| WO-1993004403-A1 | PHOTOGRAPHIC PRODUCTS AND PROCESSES | POLAROID CORPORATION (US) | 1993-03-04 | — | — | WO | disclosed |
| US-4835312-A | Production process of N-substituted amide compounds | MITSUI CHEMICALS, INCORPORATED (JP) | 1989-05-30 | — | — | US | disclosed |
| US-4211711-A | Method of preparing phthalide | DYNAMIT NOBEL AKTIENGESELLSCHAFT (DE) | 1980-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070031514-A1 | Use of isoindolinone derivatives as insecticides | DDT, CYP1A2, CYP1A1 | ALDH1A1 47/4885KDM4E 3128/4885HSD17B10 821/4885 |
| US-20210198222-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CCNT1, CCNA1 | ALDH1A1 354/4885KDM4E 4156/4885HSD17B10 2746/4885 |
| US-11691957-B2 | Condensed cyclic compound and organic light-emitting device including the same | CRY1, CCNT1, CCNA1 | ALDH1A1 354/4885KDM4E 4156/4885HSD17B10 2746/4885 |
| US-20230233551-A1 | COMPOSITIONS AND METHODS FOR TREATMENT | ICAM1, VCAM1, ITGAL | ALDH1A1 116/4885KDM4E 2998/4885HSD17B10 3634/4885 |
| US-20210338839-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETIC RETINOPATHY | VCAM1, ITGB1, ICAM1 | ALDH1A1 164/4885KDM4E 2791/4885HSD17B10 3181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.